Prolactinoma
📧 Sign up to get email alerts when something new happens for Prolactinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
This clinical trial update notes that the NICHD study on pituitary tumors and related hypothalamic disorders is actively recruiting, coverin…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Safety and Potency of a High Cabergoline Dosage in Microprolactinomas [Phase 3]
A Phase 3 clinical trial is evaluating the safety and efficacy of a high-dose cabergoline regimen in people with microprolactinomas. The stu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Pasireotide in People With Prolactinoma [Phase 2]
A Phase 2 clinical trial evaluating pasireotide for prolactinoma (prolactin-producing pituitary tumor) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
This clinical trial investigates whether estrogen fluctuations before diagnosis influence the size of prolactin-secreting pituitary tumors (…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: The PROMISE Survey
The PROMISE Survey trial update provides status information on a University Hospital Basel study; it targets prolactinoma and pituitary aden…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Validation of a Quality of Life Metric "Prolac-10"
The study validating the Prolac-10 quality-of-life metric for prolactin-producing pituitary tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment [Phase 4]
Phase 4 clinical trial examining metabolic outcomes in prolactinoma patients on dopamine agonist therapy. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma [NA]
This clinical trial update investigates surgical and pharmacological approaches for Knosp Grade 0-2 prolactinomas. The study status is NOT_Y…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Clinical trial update on a study investigating withdrawal of dopamine agonists in patients with invasive prolactinomas involving the caverno…
-
CLINICAL_TRIALS research · 2015-07-31Clinical Trial Update: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools [NA]
A clinical trial update from Unity Health Toronto assessing patient education tools for pituitary disorders; no phase or results information…
-
CLINICAL_TRIALS research · 2011-11-01Clinical Trial Update: Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients [Phase 1]
Phase 1 clinical trial evaluating turmeric's effect on serum prolactin levels and adenoma size in prolactinoma patients.
-
CLINICAL_TRIALS research · 2010-06-14Clinical Trial Update: Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas. [NA]
This clinical trial update evaluates rapid escalation of cabergoline dosing versus conventional dosing for prolactin-secreting macroadenomas…